San Fran, I to strongly agree we do need more communication from management regarding some of the points you listed. Management may not be able to comment for legal reasons being in current negotiations and can't comment until finalized, As for the citi loan perhaps they have a plan in place but as well negotiations are not finalized. My issue is even more communication this stock is absolute unknown to most of the investment public including a lot of retail biotech investors, Rvx is a complete unknown trading the Tsx which is difficult to buy shares from US investors or foreign investors other than the otccb , is Rvx that diamond in the rough ready to explode in the near future once one of several catalyst are completed. Another point in the difficulty of shareholder value is that there is zero credible brokerage and banking analyst coverage thus not a lot of share purchase from those firms or institutions purchases . Brokers and banking coverage need a reason to start covering your company and if they are not making money from equity or debt financing or an iPo ,they have no reason your stock, crazy but true. The odd time they do mostly not. For this reason I think Rvx may want to think getting that share price to $3.00 to finally get on the Nasdaq, it would definitely open on wide and varied investing public. Let's hope that communication you mentioned start happening